RU93005334A - Производные стероидов для лечения гипертрофии предстательной железы, способ их получения, использование, фармкомпозиция - Google Patents
Производные стероидов для лечения гипертрофии предстательной железы, способ их получения, использование, фармкомпозицияInfo
- Publication number
- RU93005334A RU93005334A RU93005334/04A RU93005334A RU93005334A RU 93005334 A RU93005334 A RU 93005334A RU 93005334/04 A RU93005334/04 A RU 93005334/04A RU 93005334 A RU93005334 A RU 93005334A RU 93005334 A RU93005334 A RU 93005334A
- Authority
- RU
- Russia
- Prior art keywords
- treatment
- alkyl
- hypertrophy
- steroids
- derivatives
- Prior art date
Links
- 206010020880 Hypertrophy Diseases 0.000 title 1
- 210000002307 Prostate Anatomy 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 claims 3
- 201000010099 disease Diseases 0.000 claims 2
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 claims 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 claims 1
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 claims 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 125000004986 diarylamino group Chemical group 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atoms Chemical class [H]* 0.000 claims 1
- 230000002265 prevention Effects 0.000 claims 1
- 201000004240 prostatic hypertrophy Diseases 0.000 claims 1
- 150000003839 salts Chemical class 0.000 claims 1
- 239000011780 sodium chloride Substances 0.000 claims 1
Claims (1)
- Предложено соединение формулы
где R1 - водород, алкил, арил-замещенный алкил или алкал, замещенный ароматическим гетероциклом; R2 - арил-замещенный алкил или алкил, замещенный ароматическим гетероциклом, или диариламино; и R3 - карбоксигруппа или группа формулы -CONHS O2R4, у которой R4 - алкил, а также его фармацевтически приемлемые соли и сложные эфиры, имеющие ценную 5альфа-редуктазную активность, которые поэтому могут использоваться для лечения и профилактики, кроме прочих заболеваний, также гипертрофию простаты, а также другие расстройства, вызываемые повышенными уровнями 5альфа-дигидротестостерона.
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP9981692 | 1992-04-20 | ||
JP04-099816 | 1992-04-20 | ||
JP03099816 | 1992-04-20 | ||
JP32804392 | 1992-12-08 | ||
JP04-328043 | 1992-12-08 | ||
JP04328043 | 1992-12-08 |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU95101838/04A Division RU2114861C1 (ru) | 1992-04-20 | 1993-04-19 | 3-ЦИАНОАНДРОСТА-3,5-ДИЕН-1717β-КАРБОНОВАЯ КИСЛОТА В КАЧЕСТВЕ ПРОМЕЖУТОЧНОГО ПРОДУКТА, СПОСОБ ПОЛУЧЕНИЯ СОЕДИНЕНИЯ |
Publications (2)
Publication Number | Publication Date |
---|---|
RU93005334A true RU93005334A (ru) | 1997-01-20 |
RU2097387C1 RU2097387C1 (ru) | 1997-11-27 |
Family
ID=26440917
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU93005334/04A RU2097387C1 (ru) | 1992-04-20 | 1993-04-19 | Стероидные соединения, способ получения соединений |
RU95101838/04A RU2114861C1 (ru) | 1992-04-20 | 1993-04-19 | 3-ЦИАНОАНДРОСТА-3,5-ДИЕН-1717β-КАРБОНОВАЯ КИСЛОТА В КАЧЕСТВЕ ПРОМЕЖУТОЧНОГО ПРОДУКТА, СПОСОБ ПОЛУЧЕНИЯ СОЕДИНЕНИЯ |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU95101838/04A RU2114861C1 (ru) | 1992-04-20 | 1993-04-19 | 3-ЦИАНОАНДРОСТА-3,5-ДИЕН-1717β-КАРБОНОВАЯ КИСЛОТА В КАЧЕСТВЕ ПРОМЕЖУТОЧНОГО ПРОДУКТА, СПОСОБ ПОЛУЧЕНИЯ СОЕДИНЕНИЯ |
Country Status (25)
Country | Link |
---|---|
US (3) | US5536714A (ru) |
EP (2) | EP0725074A3 (ru) |
JP (1) | JP2514778B2 (ru) |
KR (1) | KR0146680B1 (ru) |
CN (2) | CN1041095C (ru) |
AT (1) | ATE154937T1 (ru) |
AU (1) | AU656852B2 (ru) |
CA (1) | CA2094300C (ru) |
CZ (2) | CZ283791B6 (ru) |
DE (1) | DE69311837T2 (ru) |
DK (1) | DK0567271T3 (ru) |
ES (1) | ES2105108T3 (ru) |
FI (1) | FI931765A (ru) |
GR (1) | GR3024896T3 (ru) |
HK (1) | HK1000303A1 (ru) |
HU (1) | HU219579B (ru) |
ID (1) | ID18576A (ru) |
IL (1) | IL105478A (ru) |
MX (1) | MX9302300A (ru) |
NO (1) | NO304891B1 (ru) |
NZ (1) | NZ247449A (ru) |
PH (1) | PH31052A (ru) |
RU (2) | RU2097387C1 (ru) |
TW (2) | TW238312B (ru) |
ZA (1) | ZA932732B (ru) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IT1259419B (it) * | 1991-05-24 | 1996-03-18 | Erba Carlo Spa | Steroidi 3-carbossi 17b - sostituiti insaturi utili come inibitori della testosterone 5 a reduttasi |
WO1993022333A1 (en) * | 1992-04-30 | 1993-11-11 | Smithkline Beecham Corporation | 17α AND 17β-SUBSTITUTED ESTRA-1,3,5(10)-TRIENE-3-CARBOXYLIC ACID |
US5641765A (en) * | 1992-11-18 | 1997-06-24 | Smithkline Beecham Corporation | 17-αand 17-βsubstituted acyl-3-carboxy-3,5-dienes and use in inhibiting 5-α-reductase |
US5683995A (en) * | 1992-11-18 | 1997-11-04 | Smithkline Beecham Corporation | 17 substituted acyl-3-carboxy 3,5-diene steroidals as α-reductase inhibitors |
GB9224148D0 (en) * | 1992-11-18 | 1993-01-06 | Smithkline Beecham Corp | Compounds |
AU7719894A (en) * | 1993-09-03 | 1995-03-22 | Smithkline Beecham Corporation | Stabilized tablet formulation |
GB9324371D0 (en) * | 1993-11-26 | 1994-01-12 | Erba Carlo Spa | Side chain fluoro substituted 3-carboxysteroids |
GB9411103D0 (en) * | 1994-06-03 | 1994-07-27 | Smithkline Beecham Corp | Compounds |
GB9415183D0 (en) * | 1994-07-28 | 1994-09-21 | Erba Carlo Spa | 3-carboxysteroids with a fluorinated side-chain |
US6117429A (en) * | 1997-08-11 | 2000-09-12 | Weider Nutrition International, Inc | Compositions and treatments for reducing potential unwanted side effects associated with long-term administration of androgenic testosterone precursors |
US5879711A (en) * | 1997-11-07 | 1999-03-09 | Sequeira; Joel A. | Stable antiandrogenic gel composition |
EP1079859B1 (en) | 1998-05-22 | 2010-07-14 | The Board Of Trustees Of The Leland Stanford Junior University | Bifunctional molecules and therapies based thereon |
US7258850B2 (en) * | 1999-05-04 | 2007-08-21 | Aradigm Corporation | Methods and compositions for treating erectile dysfunction |
US6428769B1 (en) * | 1999-05-04 | 2002-08-06 | Aradigm Corporation | Acute testosterone administration |
JP4490689B2 (ja) * | 2001-10-03 | 2010-06-30 | メルク・シャープ・エンド・ドーム・コーポレイション | アンドロゲン受容体調節剤としてのアンドロスタン17β−カルボキサミド類 |
US20030148987A1 (en) * | 2001-12-21 | 2003-08-07 | Morris David J. | Selective 11beta-HSD inhibitors and methods of use thereof |
US20060148725A1 (en) * | 2001-12-21 | 2006-07-06 | The Miriam Hospital | Selective 11beta HSD inhibitors and methods of use thereof |
US20050020550A1 (en) * | 2003-04-29 | 2005-01-27 | Morris David J. | Selective testicular 11beta-HSD inhibitors and methods of use thereof |
DK1889198T3 (da) | 2005-04-28 | 2015-02-09 | Proteus Digital Health Inc | Farma-informatiksystem |
US9062126B2 (en) | 2005-09-16 | 2015-06-23 | Raptor Pharmaceuticals Inc. | Compositions comprising receptor-associated protein (RAP) variants specific for CR-containing proteins and uses thereof |
US7604386B2 (en) * | 2005-11-18 | 2009-10-20 | Federal-Mogul World Wide, Inc | Lamp assembly having a socket made from high temperature plastic |
DK2398500T3 (da) | 2009-02-20 | 2019-05-13 | 2 Bbb Medicines B V | Glutathion-baseret lægemiddelafgivelsessystem |
IL255113B (en) | 2009-05-06 | 2022-09-01 | Laboratory Skin Care Inc | Preparations for administration through the skin that include complexes of an active substance with calcium phosphate and methods of using them |
US8563728B2 (en) * | 2009-07-09 | 2013-10-22 | Aurobindo Pharma Ltd. | Process for the preparation of Dutasteride |
CN111362999B (zh) * | 2020-03-16 | 2022-03-29 | 江苏联环药业股份有限公司 | 一种爱普列特杂质及其制备方法和应用 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU527030B2 (en) * | 1978-04-13 | 1983-02-10 | Merck & Co., Inc. | 4-aza-17-substituted-5a-androstan-3-ones |
NZ211145A (en) * | 1984-02-27 | 1988-10-28 | Merck & Co Inc | 4-aza-5-alpha-androst-1-en-3-ones and pharmaceutical compositions |
US4910226A (en) * | 1987-04-29 | 1990-03-20 | Smithkline Beckman Corporation | Steroid 5-alpha-reductase inhibitors |
US4946834A (en) * | 1988-12-23 | 1990-08-07 | Smithkline Beecham Corporation | Phosphonic acid substituted steroids as steroid 5α-reductase inhibitors |
US5032586A (en) * | 1989-08-24 | 1991-07-16 | Smithkline Beecham Corporation | 7-keto or hydroxy 3,5-diene steroids as inhibitors of steroid 5-alpha reductase |
US5137882A (en) * | 1990-06-11 | 1992-08-11 | Holt Dennis A | Steroidal 3-acetic acid derivatives as 5-alpha-reductase inhibitors |
US5091380A (en) * | 1990-06-28 | 1992-02-25 | Merck & Co., Inc. | N-monosubstituted adamantyl/norbornanyl 17β-carbamides of 3-carboxy-androst-3,5-dienes as testosterone 5α-reductase inhibitors |
IE76452B1 (en) * | 1990-10-29 | 1997-10-22 | Sankyo Co | Azasteroid compounds for the treatment of prostatic hypertrophy their preparation and use |
AU1893492A (en) * | 1991-04-17 | 1992-11-17 | Merck & Co., Inc. | Pharmaceutical combination for the treatment of benign prostatic hyperplasia comtaining a 5 alpha-reductase inhibitor |
US5196411A (en) * | 1991-08-16 | 1993-03-23 | Merck & Co., Inc. | 17β-acyl-3-carboxy-androsta-3,5-dienes as testosterone 5α-reductase inhibitors |
-
1993
- 1993-04-15 EP EP96104843A patent/EP0725074A3/en not_active Withdrawn
- 1993-04-15 AT AT93302937T patent/ATE154937T1/de not_active IP Right Cessation
- 1993-04-15 DK DK93302937.3T patent/DK0567271T3/da active
- 1993-04-15 ES ES93302937T patent/ES2105108T3/es not_active Expired - Lifetime
- 1993-04-15 EP EP93302937A patent/EP0567271B1/en not_active Expired - Lifetime
- 1993-04-15 DE DE69311837T patent/DE69311837T2/de not_active Expired - Fee Related
- 1993-04-16 NO NO931401A patent/NO304891B1/no not_active IP Right Cessation
- 1993-04-19 FI FI931765A patent/FI931765A/fi unknown
- 1993-04-19 AU AU36984/93A patent/AU656852B2/en not_active Ceased
- 1993-04-19 RU RU93005334/04A patent/RU2097387C1/ru not_active IP Right Cessation
- 1993-04-19 CA CA002094300A patent/CA2094300C/en not_active Expired - Fee Related
- 1993-04-19 ZA ZA932732A patent/ZA932732B/xx unknown
- 1993-04-19 RU RU95101838/04A patent/RU2114861C1/ru not_active IP Right Cessation
- 1993-04-19 HU HU9301155A patent/HU219579B/hu not_active IP Right Cessation
- 1993-04-19 PH PH46066A patent/PH31052A/en unknown
- 1993-04-20 CN CN93105911A patent/CN1041095C/zh not_active Expired - Fee Related
- 1993-04-20 MX MX9302300A patent/MX9302300A/es unknown
- 1993-04-20 TW TW082103024A patent/TW238312B/zh active
- 1993-04-20 CZ CZ93678A patent/CZ283791B6/cs not_active IP Right Cessation
- 1993-04-20 CZ CZ97900A patent/CZ284206B6/cs not_active IP Right Cessation
- 1993-04-20 TW TW083108455A patent/TW401420B/zh not_active IP Right Cessation
- 1993-04-20 JP JP5092840A patent/JP2514778B2/ja not_active Expired - Fee Related
- 1993-04-20 KR KR1019930006652A patent/KR0146680B1/ko not_active IP Right Cessation
- 1993-04-20 NZ NZ247449A patent/NZ247449A/en unknown
- 1993-04-21 IL IL105478A patent/IL105478A/en not_active IP Right Cessation
- 1993-04-27 ID IDP980293A patent/ID18576A/id unknown
-
1995
- 1995-01-19 US US08/375,264 patent/US5536714A/en not_active Expired - Fee Related
- 1995-03-31 US US08/414,909 patent/US5760025A/en not_active Expired - Fee Related
-
1996
- 1996-03-20 US US08/618,850 patent/US5717088A/en not_active Expired - Fee Related
-
1997
- 1997-08-26 CN CN97117777A patent/CN1195666A/zh active Pending
- 1997-09-25 HK HK97101841A patent/HK1000303A1/xx not_active IP Right Cessation
- 1997-10-01 GR GR970402543T patent/GR3024896T3/el unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU93005334A (ru) | Производные стероидов для лечения гипертрофии предстательной железы, способ их получения, использование, фармкомпозиция | |
KR950002755A (ko) | 워트마닌 및 그의 유사체에 의한 포스파티딜이노시톨 3-키나제의 억제 | |
ES2102154T3 (es) | Inhibicion de trombina. | |
RU95104885A (ru) | 1h-индол-3-глиоксиламиды, ингибирующие spla2-медируемое выделение жирных кислот, фармацевтическая композиция | |
ES2105108T3 (es) | Esteroides para el tratamiento de la hipertrofia prostatica, su preparacion y su utilizacion. | |
RU2203274C2 (ru) | Спироциклические ингибиторы металлопротеаз | |
BG102600A (en) | Carbamoyloxy derivatives of mutilin and their use as bactericides | |
EP0948327A4 (en) | ANTIDIABETIC AGENTS | |
DK0863136T3 (da) | Azetidin- og pyrrolidinderivater | |
EA200101077A1 (ru) | Композиция для профилактики или лечения слабоумия, включающая производное гидроксикоричной кислоты или экстракт растения рода angelicae, содержащий его | |
RU94045149A (ru) | Средство ингибирования легочных гипертонических заболеваний | |
DE3462504D1 (de) | Indole-3-carboxamide derivatives | |
CA2108903A1 (en) | Substituted dibenzoxazepine compounds, pharmaceutical compositions and methods of use | |
CA2321188A1 (en) | Derivatives of azetidine and pyrrolidine | |
KR950703941A (ko) | 일산화질소 합성 억제제(nitrogen monoxide synthesis inhibitor) | |
EA200100297A1 (ru) | Моногидрат гидробромида элетриптана | |
KR960017663A (ko) | 결합 수용체 길항물질 | |
ATE45738T1 (de) | 1-cyclopropyl-1,4-dihydro-4-oxo-7-(4-(2-oxo-1,3 dioxol-4-yl-methyl)-1-piperazinyl>-3chinolincarbons|uren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel. | |
HUP0301010A2 (hu) | A koleszteril-észter és a viaszészter szintézisét egyaránt gátló vegyületek faggyúmirigy-betegségek kezeléséhez és ezeket tartalmazó gyógyszerkészítmények | |
YU17999A (sh) | Novi derivati pentaeritrita, njihova izrada i primena kao i međuproizvodi za njihovu sintezu | |
FR2389622A1 (ru) | ||
KR940021524A (ko) | 1,2,5,6-테트라하이드로피리딘 유도체와 이의 제조 방법 및 치료시 이의 이용방법 | |
AR019664A1 (es) | Composicion para el tratamiento de enfermedades del cartilago | |
ES2094132T3 (es) | Uso de derivados de xantina contra la ulcera peptica. | |
KR940005541A (ko) | 치환된 벤조에이트 유도체 |